Advertisement

Topics

Sanofi and Regeneron Hit Asthma Phase III Endpoints With Dupixent

09:28 EDT 11 Sep 2017 | SCRIP

Dupixent has upped the ante on Nucala and Cinqair, showing broad activity in Phase III in asthma. But will it...

      

Related Stories

 

Original Article: Sanofi and Regeneron Hit Asthma Phase III Endpoints With Dupixent

NEXT ARTICLE

More From BioPortfolio on "Sanofi and Regeneron Hit Asthma Phase III Endpoints With Dupixent"

Quick Search
Advertisement
 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...